Nab-paclitaxel/bevacizumab/carboplatin chemotherapy in first-line triple negative metastatic breast cancer.
about
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the LiteratureThe role of taxanes in triple-negative breast cancer: literature reviewAlbumin-bound paclitaxel in solid tumors: clinical development and future directionsClinical Translation of Nanomedicine.Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer.Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.Standard of care and promising new agents for triple negative metastatic breast cancerProspective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trialnab-Paclitaxel for the treatment of breast cancer: an update across treatment settingsNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis.Safety and efficacy evaluation of albumin-bound paclitaxel.Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung CancerMetronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
P2860
Q26745420-9E73C8F2-17B7-4F94-AEDA-BBBC634F1969Q26779880-8D40C59C-1BBE-4A82-BBDE-EAD2259D327EQ26798356-832F03B3-CE6F-4C72-813F-6E802923BBA1Q26798674-2AA90B93-27A6-4F37-820F-0B237C547247Q30355939-66D54076-285B-4289-9E3F-A078F0901ADDQ33628383-E8839B2C-B043-484D-94B5-2754653A9F16Q34570508-21A283EE-F82A-4B1F-8481-A814F1163CEBQ34774884-5EF7D2EE-340C-4853-893E-463D54D16DBDQ36326026-5D0E3FDC-879B-4BA7-9184-9D7653AE8C97Q36379813-81680697-362B-4347-97D6-46C4C1CB1A24Q37715554-57718178-BFC1-467F-8F08-9AB56986BE70Q37725620-149797B4-5E27-4B1C-A909-B4774D7E2DB9Q38190090-6D165D90-B418-4635-9AA9-F5D4491F3B22Q41536996-E1DA1647-4CA2-4E91-BBB8-8C71EF5E68CDQ47732726-D6ADEC89-FEFB-441F-B2EB-91041062AFDC
P2860
Nab-paclitaxel/bevacizumab/carboplatin chemotherapy in first-line triple negative metastatic breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@ast
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@en
type
label
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@ast
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@en
prefLabel
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@ast
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@en
P2093
P1476
Nab-paclitaxel/bevacizumab/car ...... tive metastatic breast cancer.
@en
P2093
Erika Hamilton
Gloria Rocha
Gretchen Kimmick
Judith Hopkins
Kimberly Blackwell
P Kelly Marcom
Renee Welch
P304
P356
10.1016/J.CLBC.2013.08.003
P407
P577
2013-10-04T00:00:00Z